Elion Therapeutics
Provider of clinical research and development services intended to treat systemic and life-threatening fungal infections. The company's services focus on the improvement of the Amphotericin B drug, en...
Valuation
$163M
Market implied
Share Price
N/A
Total Raised
$111M
Last Round
N/A